Dr. Reddy’s Laboratories Ltd. ADR (NYSE: RDY) is -17.73% lower on its value in year-to-date trading and has touched a low of $12.62 and a high of $16.89 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The RDY stock was last observed hovering at around $12.92 in the last trading session, with the day’s gains setting it 0.07%.
Currently trading at $12.99, the stock is -2.85% and -9.00% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.06 million and changing 0.54% at the moment leaves the stock -13.60% off its SMA200. RDY registered -14.61% loss for a year compared to 6-month loss of -19.91%.
The stock witnessed a -6.14% gain in the last 1 month and extending the period to 3 months gives it a -9.16%, and is 0.31% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 1.69% over the week and 1.28% over the month.
Dr. Reddy’s Laboratories Ltd. ADR (RDY) has around 27048 employees, a market worth around $10.82B and $3.72B in sales. Current P/E ratio is 16.89 and Fwd P/E is 16.17. Profit margin for the company is 17.25%. Distance from 52-week low is 2.93% and -23.10% from its 52-week high. The company has generated returns on investments over the last 12 months (16.88%).
with sales reaching $83.23B over the same period.The EPS is expected to shrink by -1.55% this year, but quarterly earnings will post 15.88% year-over-year. Quarterly sales are estimated to grow 17.50% in year-over-year returns.
The shares outstanding are 834.42M, and float is at 833.08M with Short Float at 2.22%.
The top institutional shareholder in the company is JPMORGAN CHASE & CO with over 0.64 million shares valued at $48.67 million. The investor’s holdings represent 1.9149 of the RDY Shares outstanding. As of 2024-06-30, the second largest holder is ROBECO INSTITUTIONAL ASSET MANAGEMENT B.V. with 2.07 million shares valued at $157.65 million to account for 1.2406 of the shares outstanding. The other top investors are ROYAL BANK OF CANADA which holds 2.06 million shares representing 1.2345 and valued at over $156.61 million, while MORGAN STANLEY holds 1.2191 of the shares totaling 2.03 million with a market value of $154.67 million.
